Larson Financial Group
BBNX icon

Larson Financial Group’s Beta Bionics BBNX Stock Holding History

Larson Financial Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.8K Buy
570
+32
+6% +$575 ﹤0.01% 2468
2026
Q2 		$8.43K Sell
538
-19
-3% -$226 ﹤0.01% 2516
2026
Q1 		$5.58K Buy
557
+280
+101% +$4.14K ﹤0.01% 2545
2025
Q4 		$8.44K Buy
+277
New +$7.4K ﹤0.01% 2214

Other funds holding BBNX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ING Group
ING Group Amsterdam, Netherlands $17.7B AUM 39.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Larson Financial Group's BBNX Position: Q3 2026 in Review

Larson Financial Group increased its Beta Bionics (BBNX) stake by 5.9% in Q3 2026, buying an estimated $575 and bringing the position to 570 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

Larson Financial Group first reported a position in BBNX in Q4 2025 and has held it in 4 quarters since. 64 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Larson Financial Group held 570 shares of Beta Bionics worth $10.8K as of Q3 2026.
  • Larson Financial Group bought 32 Beta Bionics shares in Q3 2026, an estimated $575.
  • Beta Bionics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2468 holding.
  • Larson Financial Group first reported a position in Beta Bionics in Q4 2025 and has held it in 4 quarters since.
  • 64 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.